Shaowei Lan

564 total citations
21 papers, 373 citations indexed

About

Shaowei Lan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shaowei Lan has authored 21 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shaowei Lan's work include Cell Adhesion Molecules Research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Shaowei Lan is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Shaowei Lan collaborates with scholars based in China, Taiwan and United States. Shaowei Lan's co-authors include Ming‐Shyue Lee, Chun‐Jung Ko, Hsin-Ying Lin, Hsiang–Po Huang, Pei‐Wen Hsiao, Cheng-Chung Huang, Chia‐Tung Shun, Guifang Zhao, Chunling Wu and Pengdong Li and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Shaowei Lan

21 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaowei Lan China 11 118 75 66 56 54 21 373
Daniel Böhmer Slovakia 12 137 1.2× 67 0.9× 79 1.2× 27 0.5× 46 0.9× 46 440
Nisha Durand United States 11 208 1.8× 102 1.4× 126 1.9× 45 0.8× 74 1.4× 24 488
Javad Verdi Iran 10 236 2.0× 60 0.8× 84 1.3× 42 0.8× 177 3.3× 17 423
Liyan Li China 15 187 1.6× 72 1.0× 191 2.9× 59 1.1× 57 1.1× 62 645
Amir Zamani Iran 5 209 1.8× 92 1.2× 105 1.6× 38 0.7× 86 1.6× 7 483
Xin Lei China 13 109 0.9× 114 1.5× 46 0.7× 60 1.1× 47 0.9× 30 439
András Piffkó Germany 10 120 1.0× 81 1.1× 25 0.4× 55 1.0× 27 0.5× 24 369
Justyna Czapla Poland 11 141 1.2× 102 1.4× 79 1.2× 21 0.4× 51 0.9× 23 361
Huo Tan China 13 216 1.8× 115 1.5× 38 0.6× 33 0.6× 131 2.4× 43 472
Elijah J. Mun United States 5 120 1.0× 56 0.7× 63 1.0× 53 0.9× 63 1.2× 7 471

Countries citing papers authored by Shaowei Lan

Since Specialization
Citations

This map shows the geographic impact of Shaowei Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaowei Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaowei Lan more than expected).

Fields of papers citing papers by Shaowei Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaowei Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaowei Lan. The network helps show where Shaowei Lan may publish in the future.

Co-authorship network of co-authors of Shaowei Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Shaowei Lan. A scholar is included among the top collaborators of Shaowei Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaowei Lan. Shaowei Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Chenchen, Rui Zhong, Yuanhua Lu, et al.. (2025). Multiple Kinase Small Molecule Inhibitor Tinengotinib (TT‐00420) Alone or With Chemotherapy Inhibit the Growth of SCLC. Cancer Science. 116(4). 951–965. 1 indexed citations
2.
Wang, Yishan, Wenjun Shao, Liang Zhang, et al.. (2025). Clinical application of minimal residual disease detection by ctDNA testing in non-small cell lung cancer: a narrative review. Translational Lung Cancer Research. 14(3). 1007–1020. 1 indexed citations
3.
Li, Huijun, Jingjing Liu, Liang Zhang, et al.. (2024). Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC. Journal for ImmunoTherapy of Cancer. 12(11). e009693–e009693. 2 indexed citations
4.
Li, Hui, Jingjing Liu, Shaowei Lan, et al.. (2023). An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report. Translational Lung Cancer Research. 12(12). 2538–2549. 2 indexed citations
5.
Lin, Hsin-Ying, Chun‐Jung Ko, Shaowei Lan, et al.. (2022). Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis. Oncogene. 41(20). 2833–2845. 9 indexed citations
6.
Li, Hui, Xiang Li, Shaowei Lan, et al.. (2022). ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China. Tumori Journal. 109(3). 276–281. 1 indexed citations
7.
Li, Hui, Rui Zhong, Chenchen Tang, et al.. (2022). Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway. Oncology Reports. 48(1). 11 indexed citations
8.
Ko, Chun‐Jung, Ching‐Tai Lee, Cheng‐Fan Lee, et al.. (2021). Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD. Cancer Research. 81(12). 3270–3282. 22 indexed citations
9.
Ko, Chun‐Jung, Ting-Wei Hsu, Shaowei Lan, et al.. (2020). Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis. Oncogene. 39(37). 5950–5963. 34 indexed citations
10.
Lan, Shaowei, Hui Li, Ying Liu, et al.. (2020). <p>A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma</p>. OncoTargets and Therapy. Volume 13. 11499–11504. 7 indexed citations
11.
Lin, Chia‐Hao, Han-Po Shih, Chun‐Jung Ko, et al.. (2019). HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis. British Journal of Cancer. 120(5). 499–511. 11 indexed citations
12.
Li, Hui, Yan Liu, Shaowei Lan, Yan Shi, & Ying Cheng. (2018). Small-Cell Lung Cancer Derived CD33+ Myeloid-Suppressor Cell Inhibits T Cell Function. Journal of Biomaterials and Tissue Engineering. 8(2). 267–272. 1 indexed citations
13.
Shen, Chun, Yüe Zhao, Hou Liu, et al.. (2018). Dynamically crosslinked carbon dots/biopolymer hydrogels exhibiting fluorescence and multi-stimuli logic-gate responses. Polymer Chemistry. 9(18). 2478–2483. 23 indexed citations
14.
Tu, Yating, Chun‐Jung Ko, Tai-Shan Cheng, et al.. (2017). The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells. Scientific Reports. 7(1). 15101–15101. 15 indexed citations
15.
Ko, Chun‐Jung, Cheng-Chung Huang, Hsin-Ying Lin, et al.. (2015). Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis. Cancer Research. 75(14). 2949–2960. 118 indexed citations
16.
Ko, Chun‐Jung, et al.. (2015). Ketamine Increases Permeability and Alters Epithelial Phenotype of Renal Distal Tubular Cells via a GSK‐3β‐Dependent Mechanism. Journal of Cellular Biochemistry. 117(4). 881–893. 12 indexed citations
17.
Li, Pengdong, Feilin Liu, Chunling Wu, et al.. (2015). Feasibility of human hair follicle-derived mesenchymal stem cells/CultiSpher®-G constructs in regenerative medicine. Cell and Tissue Research. 362(1). 69–86. 19 indexed citations
19.
Lan, Shaowei, Feilin Liu, Guifang Zhao, et al.. (2015). Cyclosporine A increases hair follicle growth by suppressing apoptosis‐inducing factor nuclear translocation: a new mechanism. Fundamental and Clinical Pharmacology. 29(2). 191–203. 10 indexed citations
20.
Wu, Chunling, Feilin Liu, Pengdong Li, et al.. (2014). Engineered Hair Follicle Mesenchymal Stem Cells Overexpressing Controlled-Release Insulin Reverse Hyperglycemia in Mice with Type l Diabetes. Cell Transplantation. 24(5). 891–907. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026